MedTrace Logo

China Liver Cancer Clinical Registry Cohort Database (HEAL)

NCT06777485 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-08-20

No results posted yet for this study

Summary

This study was led by the Department of Hepatobiliary Surgery of the First Affiliated Hospital of the University of Science and Technology of China (USTC), in close cooperation with many participating units across the country, to establish a standardized clinical information database of hepatocellular carcinoma cohorts, which will provide a guarantee for conducting high-quality real-world clinical studies and clinical research.

Conditions

Interventions

PROCEDURE

Procedure/Surgery treatment

Routine surgical operations for patients with hepatocellular carcinoma, such as surgical resection, ablation，TACE，HAIC

DRUG

Anti-Tumor Drugs

Use of anti-tumor drugs, e.g., immunologic, targeted, and chemotherapy drugs

Sponsors & Collaborators

  • Anhui Provincial Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2035-01-01
Completion
2035-01-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06777485 on ClinicalTrials.gov